Improving Compliance With Metformin
Phase 2
Completed
- Conditions
- Diabetes
- Registration Number
- NCT00018616
- Lead Sponsor
- US Department of Veterans Affairs
- Brief Summary
This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.
- Detailed Description
The active intervention, MEMS Feedback, involves review of patients' medication-taking over the preceding weeks
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 79
Inclusion Criteria
- Metformin has been prescribed
- Willing to use medication containers with MEMS caps
- Capable of giving informed consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie metformin adherence improvement using MEMS caps in diabetes management?
How does MEMS Feedback compare to standard-of-care interventions for metformin compliance in type 2 diabetes patients?
Are there specific biomarkers associated with enhanced metformin adherence in veterans with diabetes?
What adverse events are commonly reported with MEMS caps in metformin therapy and how are they managed?
How effective are MEMS caps compared to other behavioral interventions like SMS reminders for diabetes medication adherence?
Trial Locations
- Locations (1)
VA Connecticut Health Care System (West Haven)
🇺🇸West Haven, Connecticut, United States
VA Connecticut Health Care System (West Haven)🇺🇸West Haven, Connecticut, United States